Peptide Education
Nerve & Neuroinflammatory Health
Educational guidance on peptides and biology relevant to nerve signaling, neuroinflammation, recovery, and whole-person neurological resilience. KirkleyCare emphasizes scientific transparency, clinical context, and the difference between established evidence and emerging research.
Protect the Nerve. Regulate the Environment. Support Recovery.
When nerve tissue becomes injured or chronically stressed, inflammatory signaling can amplify pain, alter sensation, disrupt autonomic function, and interfere with the body’s normal repair response.
The goal of nerve health is therefore not simply to turn off a pain signal. It is to understand why the nerve is being injured and support the biological systems that allow nerve tissue to survive, repair, and function.
ARA-290 and KPV approach this environment through very different biological pathways.Nerve Health Is More Than Pain Control
Peripheral nerves carry sensory, motor, and autonomic information between the brain, spinal cord, organs, skin, and muscles.
When nerve tissue is damaged, the surrounding biological environment matters. Immune signaling, metabolic health, blood supply, oxidative stress, tissue compression, and the underlying cause of injury can all influence whether symptoms improve or persist.
Inflammatory Balance
Acute inflammation can participate in repair, while persistent inflammatory signaling may contribute to ongoing nerve sensitization and dysfunction.
Cellular Protection
Injured nerve tissue needs pathways that support cell survival and limit unnecessary secondary tissue damage.
Repair & Regeneration
Recovery may require restoration of nerve fibers, healthier local tissue, vascular support, and appropriate cellular signaling.
Restore Function
The ultimate goal is not simply lower pain scores, but healthier sensation, autonomic function, mobility, and quality of life.
Understanding Small-Fiber Neuropathy
Small-fiber neuropathy involves damage or dysfunction of small sensory and autonomic nerve fibers.
Because these fibers perform different jobs, symptoms may extend well beyond simple numbness.
Sensory Nerve Symptoms
- Burning discomfort
- Tingling or pins-and-needles sensations
- Shooting or electric sensations
- Altered temperature sensation
- Abnormal sensitivity to touch
- Numbness or altered sensation
Autonomic Nerve Symptoms
- Changes in sweating
- Temperature regulation problems
- Heart-rate or blood-pressure responses
- Gastrointestinal symptoms
- Exercise intolerance in some conditions
- Other involuntary nervous-system symptoms
How Nerve Recovery Comes Together
Regulate Inflammatory Signaling
Persistent inflammatory signaling can contribute to tissue stress and altered nerve sensitivity.
Protect Injured Cells
Tissue-protective signaling may help shift the local environment away from continued injury and toward survival and repair.
Support Nerve Repair
Repair involves healthier cellular signaling, local tissue support, and restoration of damaged small nerve fibers.
Restore Function
Successful nerve recovery ultimately means improving sensation, physical function, autonomic function, and quality of life.
Nerve & Neuroinflammatory Peptides
ARA-290 / Cibinetide
ARA-290, also known as cibinetide, is an experimental 11-amino-acid peptide derived from erythropoietin-related biology.
It was designed to retain tissue-protective and inflammation-regulating signaling associated with erythropoietin without producing its traditional red-blood-cell-stimulating effect.
KPV
KPV is a small three-amino-acid peptide consisting of lysine-proline-valine and derived from the C-terminal region of alpha-melanocyte-stimulating hormone.
Its strongest evidence centers on anti-inflammatory and immune-regulating signaling, rather than direct human nerve regeneration.
The Innate Repair Receptor
Erythropoietin is best known for stimulating production of red blood cells, but erythropoietin biology also includes tissue-protective signaling.
ARA-290 was engineered to focus on this tissue-protective pathway without intentionally stimulating erythropoiesis.
A Simplified View
The proposed innate repair receptor involves interaction between the erythropoietin receptor and the beta-common receptor CD131.
Why This Is Different From Traditional Pain Control
Traditional neuropathic-pain medications generally aim to reduce the perception or transmission of pain. ARA-290 research has examined whether tissue-protective signaling might also influence the underlying injured nerve environment.
What Has ARA-290 Shown in Humans?
Sarcoidosis-Associated Small-Fiber Neuropathy
Phase II clinical research evaluated ARA-290 in people with sarcoidosis-associated small-fiber neuropathy and reported improvements in validated neuropathic symptom measures.
Objective Small Nerve-Fiber Changes
Researchers also reported increases in small nerve-fiber measurements, including corneal nerve fibers. Later Phase 2b research found increases in small nerve-fiber abundance in the cornea and skin.
Pain Thresholds, Function & Quality of Life
Human studies have also examined sensory pain thresholds, physical functioning, and quality-of-life measures.
Painful Diabetic Neuropathy
ARA-290 has also undergone Phase II investigation in patients with type 2 diabetes and painful neuropathy, extending the research beyond sarcoidosis-associated nerve disease.
Promising Does Not Mean Established
These studies provide substantially more human evidence than is available for many experimental peptides, but trial populations remain relatively small. Larger and longer studies are needed to establish which neuropathies respond, optimal treatment duration, long-term safety, and durability of benefit.
Areas of Nerve & Neuroinflammatory Research
Small-Fiber Neuropathy
One of the most important human research areas for ARA-290, including both subjective symptoms and objective nerve-fiber measurements.
Neuroinflammatory Signaling
Persistent inflammatory signaling can contribute to altered nerve sensitivity and tissue stress. KPV and ARA-290 approach inflammatory biology through different mechanisms.
Diabetic Neuropathy
Metabolic dysfunction and elevated glucose can damage peripheral nerves and microvascular structures. ARA-290 has undergone human clinical research in painful diabetic neuropathy.
Autonomic Nerve Function
Small autonomic fibers influence sweating, cardiovascular responses, gastrointestinal activity, temperature regulation, and other involuntary functions.
Nerve Regeneration
Objective small-fiber changes seen in ARA-290 research have made nerve restoration an important area of continued investigation. It remains inappropriate to promise nerve regeneration for an individual patient.
Immune–Nerve Interaction
Immune cells and nerves communicate continuously. This interaction is increasingly important in research involving chronic pain, neuropathy, tissue injury, and inflammatory disease.
Evidence & Regulatory Perspective
ARA-290 — Human Clinical Research Available
ARA-290/cibinetide has progressed into Phase II human clinical research, particularly in small-fiber neuropathy associated with sarcoidosis and type 2 diabetes.
KPV — Primarily Preclinical
KPV has compelling anti-inflammatory laboratory and animal research involving NF-κB, MAP kinase pathways, immune cells, and inflammatory cytokine signaling, but direct human nerve-treatment evidence is lacking.
Neither Is FDA Approved for Neuropathy
Neither ARA-290/cibinetide nor KPV is an FDA-approved treatment for peripheral neuropathy, small-fiber neuropathy, neuropathic pain, or neuroinflammatory disease.
U.S. Compounding Status Is Separate From Drug Approval
FDA’s 2026 503A bulk-substance materials list cibinetide (ARA-290) among substances nominated without adequate support for inclusion on the 503A Bulks List. KPV-related substances were separately reviewed by FDA’s Pharmacy Compounding Advisory Committee in July 2026.
Compounding-list evaluation is a different regulatory process from FDA drug approval and does not establish safety or effectiveness for a clinical indication.
The Bigger Picture
Nerve symptoms should prompt a broader question:
Why is the nerve being injured?
Supporting nerve-repair pathways without addressing an ongoing cause of injury may limit recovery.
Interested in Nerve & Neuroinflammatory Health?
Schedule a personalized wellness consultation to discuss your symptoms, health history, metabolic factors, nerve-health goals, and available options.
Book a Wellness ConsultationSelected Scientific References
ARA-290 in sarcoidosis-associated small nerve-fiber loss, neuropathic symptoms, and corneal nerve-fiber density.
View on PubMed →
Review of Phase II ARA-290 research in sarcoidosis-associated small-fiber neuropathy.
View on PubMed →
Phase II investigation of ARA-290 in type 2 diabetes and painful neuropathy.
View on PubMed →
Cibinetide and objective small nerve-fiber abundance in sarcoidosis.
View on PubMed →
KPV effects on NF-κB, MAP kinase signaling, inflammatory cytokines, and experimental inflammation.
View on PubMed →
Section 503A bulk drug-substance nomination status for cibinetide and federal review of KPV-related bulk substances.
View FDA Information →
How to Think About This Topic
Nerve and neuroinflammatory health is rarely about a single pathway. Symptoms and function can be influenced by sleep, metabolic health, stress physiology, immune signaling, recovery capacity, nutrition, movement, and broader inflammatory load.
- Nerve signaling
- Inflammatory load
- Recovery factors
- Evidence context
Educational Only
This page is educational and does not diagnose, treat, or replace individualized medical care.
Systems-Based Health
Sleep, nutrition, movement, metabolism, stress, inflammation, and recovery all interact. Better health happens when the whole system works together.
Consultation First
If you want help thinking through symptoms, recovery factors, and evidence-informed wellness strategies, schedule a consultation with KirkleyCare.
Need Personalized Guidance?
Book a consultation if you want a more thoughtful, individualized discussion of nerve, recovery, and wellness questions.